Abstract
Cadmium (Cd) is an environmental contaminant, highly toxic to humans. This biologically non-essential element accumulates in the body, especially in the kidney, liver, lung and brain and can induce several toxic effects, depending on the concentration and the exposure time. Cd has been linked to Alzheimer’s disease (AD) as a probable risk factor, as it shows higher concentrations in brain tissues of AD patients than in healthy people, its implication in the formation of neurofibrillary tangles and in the aggregation process of amyloid beta peptides (AβPs). AβPs seem to have toxic properties, particularly in their aggregated state; insoluble AβP forms, such as small and large aggregates, protofibrils and fibrils, appear to be implicated in the pathogenesis of AD. In our study, we have evaluated the effect of Cd, at different concentrations, both on the AβP1–42 ion channel incorporated in a planar lipid membrane made up of phosphatidylcholine containing 30 % cholesterol and on the secondary structure of AβP1–42 in aqueous environment. Cadmium is able to interact with the AβP1–42 peptide by acting on the channel incorporated into the membrane as well as on the peptide in solution, both decreasing AβP1–42 channel frequency and in solution forming large and amorphous aggregates prone to precipitate. These experimental observations suggesting a toxic role for Cd strengthen the hypothesis that Cd may interact directly with AβPs and may be a risk factor in AD.
Similar content being viewed by others
References
Abramov AY, Ionov M, Pavlov E, Duchen MR (2011) Membrane cholesterol content plays a key role in the neurotoxicity of β-amyloid: implications for Alzheimer’s disease. Aging Cell 10:595–603
Alberdi E, Sánchez-Gómez MV, Cavaliere F, Pérez-Samartín A, Zugaza JL, Trullas R, Domercq M, Matute C (2010) Amyloid beta oligomers induce Ca2+ dysregulation and neuronal death through activation of ionotropic glutamate receptors. Cell Calcium 47:264–272
Arispe N, Pollard H, Rojas E (1993a) Giant multilevel cation channels formed by Alzheimer disease amyloid beta-protein [A beta P-(1-40)] in bilayer membranes. Proc Natl Acad Sci USA 90:10573–10577
Arispe N, Rojas E, Pollard H (1993b) Alzheimer disease amyloid beta protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum. Proc Natl Acad Sci USA 90:567–571
Arispe N, Pollard H, Rojas E (1996) Zn2+ interaction with Alzheimer amyloid beta protein calcium channels. Proc Natl Acad Sci USA 93:1710–1715
Ashley R, Harroun T, Hauss T, Breen K, Bradshaw J (2006) Autoinsertion of soluble oligomers of Alzheimer’s Abeta(1-42) peptide into cholesterol-containing membranes is accompanied by relocation of the sterol towards the bilayer surface. BMC Struct Biol 6:21
Basun H, Forssell L, Wetterberg L, Winblad B (1991) Metals and trace elements in plasma and cerebrospinal fluid in normal aging and Alzheimer’s disease. J Neural Transm Park Dis Dement Sect 3:231–258
Bitan G, Fradinger EA, Spring SM, Teplow DB (2005) Neurotoxic protein oligomers—what you see is not always what you get. Amyloid 12:88–95
Bocharova OV, Breydo L, Salnikov VV, Baskakov IV (2005) Copper(II) inhibits in vitro conversion of prion protein into amyloid fibrils. Biochemistry 44:6776–6787
Bolognin S, Messori L, Drago D, Gabbiani C, Cendron L, Zatta P (2011) Aluminum, copper, iron and zinc differentially alter amyloid-Aβ(1-42) aggregation and toxicity. Int J Biochem Cell Biol 43:877–885
Bravard A, Vacher M, Gouget B, Coutant A, de Boisferon FH, Marsin S, Chevillard S, Radicella JP (2006) Redox regulation of human OGG1 activity in response to cellular oxidative stress. Mol Cell Biol 26:7430–7436
Bush A (2000) Metals and neuroscience. Curr Opin Chem Biol 4:184–191
Bush A (2003) The metallobiology of Alzheimer’s disease. Trends Neurosci 26:207–214
Caughey B, Lansbury PT (2003) Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu Rev Neurosci 26:267–298
Chauhan V, Chauhan A (2006) Oxidative stress in Alzheimer’s disease. Pathophysiology 13:195–208
Chen WT, Liao YH, Yu HM, Cheng IH, Chen YR (2011) Distinct effects of Zn2+, Cu2+, Fe3+, and Al3+ on amyloid-beta stability, oligomerization, and aggregation: amyloid-beta destabilization promotes annular protofibril formation. J Biol Chem 286:9646–9656
Davis CH, Berkowitz ML (2010) A molecular dynamics study of the early stages of amyloid-beta(1-42) oligomerization: the role of lipid membranes. Proteins 78:2533–2545
De Felice FG, Velasco PT, Lambert MP, Viola K, Fernandez SJ, Ferreira ST, Klein WL (2007) Abeta oligomers induce neuronal oxidative stress through an N-methyl-d-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine. J Biol Chem 282:11590–11601
Di Carlo M (2010) Beta amyloid peptide: from different aggregation forms to the activation of different biochemical pathways. Eur Biophys J 39:877–888
Di Paolo G, Kim TW (2011) Linking lipids to Alzheimer’s disease: cholesterol and beyond. Nat Rev Neurosci 12:284–296
Drago D, Bettella M, Bolognin S, Cendron L, Scancar J, Milacic R, Ricchelli F, Casini A, Messori L, Tognon G et al (2008) Potential pathogenic role of beta-amyloid(1-42)-aluminum complex in Alzheimer’s disease. Int J Biochem Cell Biol 40:731–746
Durell S, Guy H, Arispe N, Rojas E, Pollard H (1994) Theoretical models of the ion channel structure of amyloid beta-protein. Biophys J 67:2137–2145
Fahim MA, Nemmar A, Dhanasekaran S, Singh S, Shafiullah M, Yasin J, Zia S, Hasan MY (2012) Acute cadmium exposure causes systemic and thromboembolic events in mice. Physiol Res 61:73–80
Gallucci E, Meleleo D, Micelli S, Picciarelli V (2003) Magainin 2 channel formation in planar lipid membranes: the role of lipid polar groups and ergosterol. Eur Biophys J 32:22–32
Gennis RB (1989) Biomembranes: molecular structure and function. Springer, New York
Glabe CG (2006) Common mechanisms of amyloid oligomer pathogenesis in degenerative disease. Neurobiol Aging 27:570–575
Gonçalves JF, Fiorenza AM, Spanevello RM, Mazzanti CM, Bochi GV, Antes FG, Stefanello N, Rubin MA, Dressler VL, Morsch VM et al (2010) N-acetylcysteine prevents memory deficits, the decrease in acetylcholinesterase activity and oxidative stress in rats exposed to cadmium. Chem Biol Interact 186:53–60
Gonçalves JF, Nicoloso FT, da Costa P, Farias JG, Carvalho FB, da Rosa MM, Gutierres JM, Abdalla FH, Pereira JS, Dias GR et al (2012) Behavior and brain enzymatic changes after long-term intoxication with cadmium salt or contaminated potatoes. Food Chem Toxicol 50:3709–3718
Ha C, Ryu J, Park CB (2007) Metal ions differentially influence the aggregation and deposition of Alzheimer’s beta-amyloid on a solid template. Biochemistry 46:6118–6125
Haass C, Selkoe DJ (1993) Cellular processing of beta-amyloid precursor protein and the genesis of amyloid beta-peptide. Cell 75:1039–1042
Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 297:353–356
Hertel C, Terzi E, Hauser N, Jakob-Rotne R, Seelig J, Kemp JA (1997) Inhibition of the electrostatic interaction between beta-amyloid peptide and membranes prevents beta-amyloid-induced toxicity. Proc Natl Acad Sci USA 94:9412–9416
Hirakura Y, Lin M, Kagan B (1999) Alzheimer amyloid abeta1-42 channels: effects of solvent, pH, and Congo Red. J Neurosci Res 57:458–466
Hotz P, Buchet JP, Bernard A, Lison D, Lauwerys R (1999) Renal effects of low-level environmental cadmium exposure: 5-year follow-up of a subcohort from the Cadmibel study. Lancet 354:1508–1513
Im JY, Paik SG, Han PL (2006) Cadmium-induced astroglial death proceeds via glutathione depletion. J Neurosci Res 83:301–308
Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N, Ihara Y (1994) Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43). Neuron 13:45–53
Jarrett JT, Berger EP, Lansbury PT (1993) The C-terminus of the beta protein is critical in amyloidogenesis. Ann N Y Acad Sci 695:144–148
Jiang LF, Yao TM, Zhu ZL, Wang C, Ji LN (2007) Impacts of Cd(II) on the conformation and self-aggregation of Alzheimer’s tau fragment corresponding to the third repeat of microtubule-binding domain. Biochim Biophys Acta 1774:1414–1421
Jin T, Lu J, Nordberg M (1998) Toxicokinetics and biochemistry of cadmium with special emphasis on the role of metallothionein. Neurotoxicology 19:529–535
Jomova K, Valko M (2011) Advances in metal-induced oxidative stress and human disease. Toxicology 283:65–87
Jones MM, Cherian MG (1990) The search for chelate antagonists for chronic cadmium intoxication. Toxicology 62:1–25
Kakio A, Nishimoto S, Kozutsumi Y, Matsuzaki K (2003) Formation of a membrane-active form of amyloid beta-protein in raft-like model membranes. Biochem Biophys Res Commun 303:514–518
Kataranovski M, Janković S, Kataranovski D, Stosić J, Bogojević D (2009) Gender differences in acute cadmium-induced systemic inflammation in rats. Biomed Environ Sci 22:1–7
Karimi MM, Jafari Sani M, Mahmudabadi AZ, Jafari Sani A, and Kathibi, RS (2012) Effect of acute toxicity of cadmium in mice kidney cells. Iran J Toxicol 6
Kayed R, Head E, Thompson J, McIntire T, Milton S, Cotman C, Glabe C (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300:486–489
Kayed R, Sokolov Y, Edmonds B, McIntire T, Milton S, Hall J, Glabe C (2004) Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases. J Biol Chem 279:46363–46366
Kirkitadze MD, Condron MM, Teplow DB (2001) Identification and characterization of key kinetic intermediates in amyloid beta-protein fibrillogenesis. J Mol Biol 312:1103–1119
Klement K, Wieligmann K, Meinhardt J, Hortschansky P, Richter W, Fändrich M (2007) Effect of different salt ions on the propensity of aggregation and on the structure of Alzheimer’s abeta(1-40) amyloid fibrils. J Mol Biol 373:1321–1333
Kuperstein I, Broersen K, Benilova I, Rozenski J, Jonckheere W, Debulpaep M, Vandersteen A, Segers-Nolten I, Van Der Werf K, Subramaniam V et al (2010) Neurotoxicity of Alzheimer’s disease Aβ peptides is induced by small changes in the Aβ42 to Aβ40 ratio. EMBO J 29:3408–3420
Lafuente A, Esquifino AI (1999) Cadmium effects on hypothalamic activity and pituitary hormone secretion in the male. Toxicol Lett 110:209–218
Lesné S, Koh M, Kotilinek L, Kayed R, Glabe C, Yang A, Gallagher M, Ashe K (2006) A specific amyloid-beta protein assembly in the brain impairs memory. Nature 440:352–357
Lesné S, Kotilinek L, Ashe KH (2008) Plaque-bearing mice with reduced levels of oligomeric amyloid-beta assemblies have intact memory function. Neuroscience 151:745–749
Li X, Lv Y, Yu S, Zhao H, Yao L (2012) The effect of cadmium on Aβ levels in APP/PS1 transgenic mice. Exp Ther Med 4:125–130
Lin H, Bhatia R, Lal R (2001) Amyloid beta protein forms ion channels: implications for Alzheimer’s disease pathophysiology. FASEB J 15:2433–2444
López E, Arce C, Oset-Gasque MJ, Cañadas S, González MP (2006) Cadmium induces reactive oxygen species generation and lipid peroxidation in cortical neurons in culture. Free Radic Biol Med 40:940–951
Lovell M, Robertson J, Teesdale W, Campbell J, Markesbery W (1998) Copper, iron and zinc in Alzheimer’s disease senile plaques. J Neurol Sci 158:47–52
Lue L, Kuo Y, Roher A, Brachova L, Shen Y, Sue L, Beach T, Kurth J, Rydel R, Rogers J (1999) Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer’s disease. Am J Pathol 155:853–862
Lui E, Fisman M, Wong C, Diaz F (1990) Metals and the liver in Alzheimer’s disease. An investigation of hepatic zinc, copper, cadmium, and metallothionein. J Am Geriatr Soc 38:633–639
Lukawski K, Nieradko B, Sieklucka-Dziuba M (2005) Effects of cadmium on memory processes in mice exposed to transient cerebral oligemia. Neurotoxicol Teratol 27:575–584
Mason RP, Jacob RF, Walter MF, Mason PE, Avdulov NA, Chochina SV, Igbavboa U, Wood WG (1999) Distribution and fluidizing action of soluble and aggregated amyloid beta-peptide in rat synaptic plasma membranes. J Biol Chem 274:18801–18807
McLean C, Cherny R, Fraser F, Fuller S, Smith M, Beyreuther K, Bush A, Masters C (1999) Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer’s disease. Ann Neurol 46:860–866
Meleleo D, Galliani A, Notarachille G (2013) AβP1-42 incorporation and channel formation in planar lipid membranes: the role of cholesterol and its oxidation products. J Bioenerg Biomembr 45:369–381
Micelli S, Gallucci E, Meleleo D, Stipani V, Picciarelli V (2002) Mitochondrial porin incorporation into black lipid membranes: ionic and gating contribution to the total current. Bioelectrochemistry 57:97–106
Micelli S, Meleleo D, Picciarelli V, Gallucci E (2004) Effect of sterols on beta-amyloid peptide (AbetaP 1-40) channel formation and their properties in planar lipid membranes. Biophys J 86:2231–2237
Minami A, Takeda A, Nishibaba D, Takefuta S, Oku N (2001) Cadmium toxicity in synaptic neurotransmission in the brain. Brain Res 894:336–339
Miyashita N, Straub JE, Thirumalai D (2009) Structures of beta-amyloid peptide 1-40, 1-42, and 1-55-the 672-726 fragment of APP-in a membrane environment with implications for interactions with gamma-secretase. J Am Chem Soc 131:17843–17852
Moschou M, Papaefthimiou C, Kagiava A, Antonopoulou E, Theophilidis G (2008) In vitro assessment of the effects of cadmium and zinc on mammalian nerve fibres. Chemosphere 71:1996–2002
Müller P, Rudin D, Tien T, Weacott W (1962) Reconstitution of cell membrane structure in vitro and its trasformation into an excitable system. Nature 194:979–980
Nishimura Y, Yamaguchi JY, Kanada A, Horimoto K, Kanemaru K, Satoh M, Oyama Y (2006) Increase in intracellular Cd(2 +) concentration of rat cerebellar granule neurons incubated with cadmium chloride: cadmium cytotoxicity under external Ca(2 +)-free condition. Toxicol In Vitro 20:211–216
Panayi A, Spyrou N, Iversen B, White M, Part P (2002) Determination of cadmium and zinc in Alzheimer’s brain tissue using inductively coupled plasma mass spectrometry. J Neurol Sci 195:1–10
Pollard HB, Rojas E, Arispe N (1993) A new hypothesis for the mechanism of amyloid toxicity, based on the calcium channel activity of amyloid beta protein (A beta P) in phospholipid bilayer membranes. Ann N Y Acad Sci 695:165–168
Quist A, Doudevski I, Lin H, Azimova R, Ng D, Frangione B, Kagan B, Ghiso J, Lal R (2005) Amyloid ion channels: a common structural link for protein-misfolding disease. Proc Natl Acad Sci USA 102:10427–10432
Raghunathan G, Seetharamulu P, Brooks BR, Guy HR (1990) Models of delta-hemolysin membrane channels and crystal structures. Proteins 8:213–225
Ragunathan N, Dairou J, Sanfins E, Busi F, Noll C, Janel N, Dupret JM, Rodrigues-Lima F (2010) Cadmium alters the biotransformation of carcinogenic aromatic amines by arylamine N-acetyltransferase xenobiotic-metabolizing enzymes: molecular, cellular, and in vivo studies. Environ Health Perspect 118:1685–1691
Ricchelli F, Drago D, Filippi B, Tognon G, Zatta P (2005) Aluminum-triggered structural modifications and aggregation of beta-amyloids. Cell Mol Life Sci 62:1724–1733
Roychaudhuri R, Yang M, Hoshi MM, Teplow DB (2009) Amyloid beta-protein assembly and Alzheimer disease. J Biol Chem 284:4749–4753
Sanderson KL, Butler L, Ingram VM (1997) Aggregates of a beta-amyloid peptide are required to induce calcium currents in neuron-like human teratocarcinoma cells: relation to Alzheimer’s disease. Brain Res 744:7–14
Scheuner D, Eckman C, Jensen M, Song X, Citron M, Suzuki N, Bird TD, Hardy J, Hutton M, Kukull W et al (1996) Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer’s disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer’s disease. Nat Med 2:864–870
Selkoe D (2001a) Alzheimer’s disease: genes, proteins, and therapy. Physiol Rev 81:741–766
Selkoe D (2001b) Clearing the brain’s amyloid cobwebs. Neuron 32:177–180
Selkoe D (2004) Cell biology of protein misfolding: the examples of Alzheimer’s and Parkinson’s diseases. Nat Cell Biol 6:1054–1061
Seubert P, Vigo-Pelfrey C, Esch F, Lee M, Dovey H, Davis D, Sinha S, Schlossmacher M, Whaley J, Swindlehurst C (1992) Isolation and quantification of soluble Alzheimer’s beta-peptide from biological fluids. Nature 359:325–327
Shafrir Y, Durell S, Arispe N, Guy HR (2010) Models of membrane-bound Alzheimer’s Abeta peptide assemblies. Proteins 78:3473–3487
Shirwany NA, Payette D, Xie J, Guo Q (2007) The amyloid beta ion channel hypothesis of Alzheimer’s disease. Neuropsychiatr Dis Treat 3:597–612
Simmons MA, Schneider CR (1993) Amyloid beta peptides act directly on single neurons. Neurosci Lett 150:133–136
Smart OS, Breed J, Smith GR, Sansom MS (1997) A novel method for structure-based prediction of ion channel conductance properties. Biophys J 72:1109–1126
Smith DG, Cappai R, Barnham KJ (2007) The redox chemistry of the Alzheimer’s disease amyloid beta peptide. Biochim Biophys Acta 1768:1976–1990
Sokolov Y, Kozak J, Kayed R, Chanturiya A, Glabe C, Hall J (2006) Soluble amyloid oligomers increase bilayer conductance by altering dielectric structure. J Gen Physiol 128:637–647
Sowa B, Steibert E (1985) Effect of oral cadmium administration to female rats during pregnancy on zinc, copper, and iron content in placenta, foetal liver, kidney, intestine, and brain. Arch Toxicol 56:256–262
Stellato F, Menestrina G, Serra MD, Potrich C, Tomazzolli R, Meyer-Klaucke W, Morante S (2006) Metal binding in amyloid beta-peptides shows intra- and inter-peptide coordination modes. Eur Biophys J 35:340–351
Stipani V, Gallucci E, Micelli S, Picciarelli V, Benz R (2001) Channel formation by salmon and human calcitonin in black lipid membranes. Biophys J 81:3332–3338
Syme CD, Viles JH (2006) Solution 1H NMR investigation of Zn2+ and Cd22+ binding to amyloid-beta peptide (Abeta) of Alzheimer’s disease. Biochim Biophys Acta 1764:246–256
Tien TH (1974) Bilayer Lipid Membrane: theory and practice. Marcel Dekker, New York
Tien TH, Mountz JD, and Martinosi AN (1977) Protein-lipid interaction in bilayer lipid membranes (BLM). In: The enzyme of biological membranes, vol 1. Plenum, NY, pp 139–170
Valincius G, Heinrich F, Budvytyte R, Vanderah D, McGillivray D, Sokolov Y, Hall J, Lösche M (2008) Soluble amyloid beta-oligomers affect dielectric membrane properties by bilayer insertion and domain formation: implications for cell toxicity. Biophys J 95:4845–4861
Vargas J, Alarcón J, Rojas E (2000) Displacement currents associated with the insertion of Alzheimer disease amyloid beta-peptide into planar bilayer membranes. Biophys J 79:934–944
Walsh D, Klyubin I, Fadeeva J, Cullen W, Anwyl R, Wolfe M, Rowan M, Selkoe D (2002) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416:535–539
Walsh DM, Townsend M, Podlisny MB, Shankar GM, Fadeeva JV, El Agnaf O, Hartley DM, Selkoe DJ (2005) Certain inhibitors of synthetic amyloid beta-peptide (Abeta) fibrillogenesis block oligomerization of natural Abeta and thereby rescue long-term potentiation. J Neurosci 25:2455–2462
Wang B, Du Y (2013) Cadmium and its neurotoxic effects. Oxid Med Cell Longev 2013:898034
Wang HY, Lee DH, Davis CB, Shank RP (2000) Amyloid peptide Abeta(1-42) binds selectively and with picomolar affinity to alpha7 nicotinic acetylcholine receptors. J Neurochem 75:1155–1161
Weiner H, Frenkel D (2006) Immunology and immunotherapy of Alzheimer’s disease. Nat Rev Immunol 6:404–416
Yano K, Hirosawa N, Sakamoto Y, Katayama H, Moriguchi T (2003) Aggregations of amyloid beta-proteins in the presence of metal ions. Toxicol Lett 144:s134
Yuan Y, Bian JC, Liu XZ, Zhang Y, Sun Y, Liu ZP (2012) Oxidative stress and apoptotic changes of rat cerebral cortical neurons exposed to cadmium in vitro. Biomed Environ Sci 25:172–181
Acknowledgments
This work was supported by a grant from the Fondazione Cassa di Risparmio di Puglia. The authors acknowledge Anthony Green for proofreading and providing linguistic advice.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Notarachille, G., Arnesano, F., Calò, V. et al. Heavy metals toxicity: effect of cadmium ions on amyloid beta protein 1–42. Possible implications for Alzheimer’s disease. Biometals 27, 371–388 (2014). https://doi.org/10.1007/s10534-014-9719-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10534-014-9719-6